00000000nam 2200000za 4500
0019.854395
003CaOODSP
00520221107155043
007cr |||||||||||
008180327s2018    onc     ob   f000 0 eng d
020 |a9780660260105
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH13-9/10-2018E-PDF
24500|aGuidance document |h[electronic resource] : |bcancellation of a drug identification number (DIN) and notification of discontinuation of sales.
24630|aCancellation of a drug identification number (DIN) and notification of discontinuation of sales
24617|aCancellation of a DIN & notification of discontinuation of sales
260 |aOttawa : |bHealth Canada, |c2018.
300 |a18 p.
500 |aIssued also in French under title: Ligne directrice : annulation d’une identification numérique d’une drogue (DIN) et avis de cessation de la vente d’une drogue.
500 |aCover title.
500 |a"Date adopted: 2017/03/14. Revision date: 2018/06/13. Effective date: 2018/06/13."
500 |a"Publication date: June 2018."
500 |aIssued also in HTML format.
504 |aIncludes bibliographical references.
520 |a"A Drug Identification Number (DIN) serves as an identifier of a drug and its associated characteristics. The assignment of a DIN indicates that a drug has undergone a successful Health Canada review process and is currently authorized for sale in Canada. The purpose of this guidance document is to provide assistance in interpreting sections C.01.014.6 and C.01.014.7 of the Regulations for the cancellation of a DIN and the notification to Health Canada of the discontinuation of the sale of a drug"--P. 7.
693 4|aDrugs
693 4|aProduct elimination
693 4|aHandbooks
7101 |aCanada. |bHealth Canada.
77508|tLigne directrice |w(CaOODSP)9.854397
85640|qPDF|s295 KB|uhttps://publications.gc.ca/collections/collection_2018/sc-hc/H13-9-10-2018-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/regulatory-requirements-drug-identification-numbers/document.html
986 |a170513